A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics
Titel:
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics
Auteur:
Casulo, Carla Vose, Julie M. Ho, William Y. Kahl, Brad Brunvand, Mark Goy, Andre Kasamon, Yvette Cheson, Bruce Friedberg, Jonathan W.